Chronic Bronchitis
Chronic Bronchitis is a respiratory condition. In this library, it is listed as a condition that may be helped by Pelargonium Sidoides, although the available grounding data does not provide further details about symptoms, causes, or how it is used.
Chronic bronchitis is a respiratory condition. This page provides a simple overview and related reference information.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
None of these options has good evidence yet. Best evidence first.
1 option:1 not enough evidence
DancepracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A qualitative study involving 8 people with COPD and asthma reported that community dance improved physical fitness, psychological well-being and social connections.
Open the Dance page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition1 listedThe best we have, but the evidence is still weak
- →PracticesDanceCertaintyLowSourceClinical
A qualitative study involving 8 people with COPD and asthma reported that community dance improved physical fitness, psychological well-being and social connections.
Who was studied
- People with a condition
Open DanceStudy result
Philip study (n=8, qualitative): community dance improved physical fitness, psychological well-being, and social connections in individuals with COPD and asthma
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making Chronic Bronchitis worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Chronic Bronchitis is a respiratory condition. In this library, it is listed as a condition that may be helped by Pelargonium Sidoides, although the available grounding data does not provide further details about symptoms, causes, or how it is used.
Because this is a medical condition, any questions about diagnosis or management are best discussed with a clinician.
Evidence-backed options
Pelargonium Sidoides is the only option in the provided data that is noted as helping Chronic Bronchitis, and the evidence is rated very low. That means it appears in the reference data as a possible supportive option, but the current evidence base is limited.
For a condition like Chronic Bronchitis, this kind of evidence is best read as suggestive rather than definitive. It may be included in educational summaries because it has been mentioned in pharmacology reference material, but the data here does not support a strong conclusion about how well it works or for whom it may be most relevant.
Because the available information is sparse, it is reasonable to view this as one item among many that a clinician might consider in the broader context of Chronic Bronchitis. Any decision about treatment or symptom management should be made with a healthcare professional who can account for the full clinical picture.